433 related articles for article (PubMed ID: 27540128)
1. Expanding Access to a New, More Affordable Levonorgestrel Intrauterine System in Kenya: Service Delivery Costs Compared With Other Contraceptive Methods and Perspectives of Key Opinion Leaders.
Rademacher KH; Solomon M; Brett T; Bratt JH; Pascual C; Njunguru J; Steiner MJ
Glob Health Sci Pract; 2016 Aug; 4 Suppl 2(Suppl 2):S83-93. PubMed ID: 27540128
[TBL] [Abstract][Full Text] [Related]
2. Experiences With the Levonorgestrel Intrauterine System Among Clients, Providers, and Key Opinion Leaders: A Mixed-Methods Study in Nigeria.
Eva G; Nanda G; Rademacher K; Mackay A; Negedu O; Taiwo A; Dal Santo L; Saleh M; Palmer L; Brett T
Glob Health Sci Pract; 2018 Dec; 6(4):680-692. PubMed ID: 30591576
[TBL] [Abstract][Full Text] [Related]
3. Experiences with the levonorgestrel-releasing intrauterine system in Kenya: qualitative interviews with users and their partners.
Nanda G; Rademacher K; Solomon M; Mercer S; Wawire J; Ngahu R
Eur J Contracept Reprod Health Care; 2018 Aug; 23(4):303-308. PubMed ID: 30198796
[TBL] [Abstract][Full Text] [Related]
4. Introduction of the levonorgestrel intrauterine system in Kenya through mobile outreach: review of service statistics and provider perspectives.
Hubacher D; Akora V; Masaba R; Chen M; Veena V
Glob Health Sci Pract; 2014 Feb; 2(1):47-54. PubMed ID: 25276562
[TBL] [Abstract][Full Text] [Related]
5. The levonorgestrel intrauterine system: cohort study to assess satisfaction in a postpartum population in Kenya.
Hubacher D; Masaba R; Manduku CK; Chen M; Veena V
Contraception; 2015 Apr; 91(4):295-300. PubMed ID: 25601351
[TBL] [Abstract][Full Text] [Related]
6. Uptake of the levonorgestrel intrauterine system among recent postpartum women in Kenya: factors associated with decision-making.
Hubacher D; Masaba R; Manduku CK; Veena V
Contraception; 2013 Jul; 88(1):97-102. PubMed ID: 23566383
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 13.5 mg in contraception.
Trussell J; Hassan F; Henry N; Pocoski J; Law A; Filonenko A
Contraception; 2014 May; 89(5):451-9. PubMed ID: 24576791
[TBL] [Abstract][Full Text] [Related]
8. Provision of the levonorgestrel intrauterine system in Nigeria: Provider perspectives and service delivery costs.
Brunie A; Rademacher KH; Nwala AA; Danna K; Saleh M; Afolabi K
Gates Open Res; 2020; 4():119. PubMed ID: 32908965
[No Abstract] [Full Text] [Related]
9. Intrauterine devices. The optimal long-term contraceptive method?
Fortney JA; Feldblum PJ; Raymond EG
J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
[TBL] [Abstract][Full Text] [Related]
10. LNG-IUS 12: a 19.5 levonorgestrel-releasing intrauterine system for prevention of pregnancy for up to five years.
Nelson AL
Expert Opin Drug Deliv; 2017 Sep; 14(9):1131-1140. PubMed ID: 28696796
[TBL] [Abstract][Full Text] [Related]
11. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
[TBL] [Abstract][Full Text] [Related]
12. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
13. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
[TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.
Mavranezouli I;
Hum Reprod; 2008 Jun; 23(6):1338-45. PubMed ID: 18372257
[TBL] [Abstract][Full Text] [Related]
15. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
Heinemann K; Reed S; Moehner S; Minh TD
Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
[TBL] [Abstract][Full Text] [Related]
16. Policy and programmatic considerations for introducing a longer-acting injectable contraceptive: perspectives of stakeholders from Kenya and Rwanda.
McKenna K; Arcara J; Rademacher KH; Mackenzie C; Ngabo F; Munyambanza E; Wesson J; Tolley EE
Glob Health Sci Pract; 2014 Oct; 2(4):459-71. PubMed ID: 25611479
[TBL] [Abstract][Full Text] [Related]
17. A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age.
Borgatta L; Buhling KJ; Rybowski S; Roth K; Rosen K
Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):372-9. PubMed ID: 27494570
[TBL] [Abstract][Full Text] [Related]
18. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium
Lancet; 2019 Jul; 394(10195):303-313. PubMed ID: 31204114
[TBL] [Abstract][Full Text] [Related]
19. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
Modesto W; Bahamondes MV; Bahamondes L
Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
[TBL] [Abstract][Full Text] [Related]
20. Acceptability of intrauterine contraception among women living with human immunodeficiency virus: a randomised clinical trial.
Kakaire O; Tumwesigye NM; Byamugisha JK; Gemzell-Danielsson K
Eur J Contracept Reprod Health Care; 2016 Jun; 21(3):220-6. PubMed ID: 26895345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
